glp 1 for weight loss pill New GLP-1 Foundayo (Orforglipron) Gets FDA Approval Obesity FDA Approves Wegovy Alternative for
Description
At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk
Clean & Allergen-Free Free from artificial colors, flavors, sweeteners, preservatives, and common allergens (milk, soy, eggs, corn, gluten, wheat, yeast, fish)
The European Medicines Agency has issued a positive recommendation on the same indication
Synthetic peptide - CAS #107444-51-9
